| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/14/2000 | CA2478736A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2478730A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2478728A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2411514A1 Nucleotide compounds having a cleavable linker |
| 09/14/2000 | CA2372306A1 Multiple component rna vector system for expression of foreign sequences |
| 09/14/2000 | CA2367334A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2367315A1 Apoptosis inducing molecule ii and methods of use |
| 09/14/2000 | CA2367313A1 Method for screening biomolecule activity regulator |
| 09/14/2000 | CA2367067A1 Heterogenous and homogeneous mouse variants lacking sno gene |
| 09/14/2000 | CA2367060A1 Plants and feed baits for controlling damage from feeding insects |
| 09/14/2000 | CA2366921A1 Novel cytokine zalpha11 ligand |
| 09/14/2000 | CA2366713A1 Antibody and chemokine constructs and their use in the treatment of autoimmune diseases |
| 09/14/2000 | CA2366706A1 Mammalian cytokines; related reagents and methods |
| 09/14/2000 | CA2366479A1 Compositions and methods for the modification of gene transcription |
| 09/14/2000 | CA2366429A1 Methods and compositions for regulating memory consolidation |
| 09/14/2000 | CA2366427A1 Dna binding proteins that interact with npr1 |
| 09/14/2000 | CA2366147A1 Casb618 polynucleotides and polypeptides and their use |
| 09/14/2000 | CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | CA2366101A1 Intact cell assay for protein tyrosine phosphatases |
| 09/14/2000 | CA2366087A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) |
| 09/14/2000 | CA2366078A1 Adipose-derived stem cells and lattices |
| 09/14/2000 | CA2366069A1 Generation of conditional yeast mutants, methods and reagents related thereto |
| 09/14/2000 | CA2366063A1 Translation regulation system and methods for use thereof |
| 09/14/2000 | CA2366058A1 Cdna molecules of the members of gene family encoding human fatty acid desaturases and their use in diagnosis and therapy |
| 09/14/2000 | CA2365968A1 Novel plant genes and uses thereof |
| 09/14/2000 | CA2365923A1 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 09/14/2000 | CA2365904A1 Mitomycin biosynthetic gene cluster |
| 09/14/2000 | CA2365903A1 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 09/14/2000 | CA2365843A1 Expression of human alpha-fetoprotein in mammalian cells |
| 09/14/2000 | CA2365813A1 Stable recombinant influenza viruses free of helper viruses |
| 09/14/2000 | CA2365799A1 Cloning and expression of haemophilus somnus transferrin-binding proteins |
| 09/14/2000 | CA2365625A1 Delivery of substances to cells |
| 09/14/2000 | CA2365293A1 Compositions and methods for recombinant adeno-associated virus production |
| 09/14/2000 | CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 09/14/2000 | CA2365226A1 Immobilising polynucleotides |
| 09/14/2000 | CA2364500A1 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use |
| 09/14/2000 | CA2364275A1 Trait-associated gene identification method |
| 09/14/2000 | CA2363593A1 Nucleic acid respiratory syncytial virus vaccines |
| 09/14/2000 | CA2363255A1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same |
| 09/14/2000 | CA2362885A1 Human kallikrein-like genes |
| 09/14/2000 | CA2362670A1 Matriptase, a serine protease and its applications |
| 09/14/2000 | CA2362445A1 Fibers having nucleic acid immobilized thereon, alignment of fibers having nucleic acid immobilized thereon and slice thereof |
| 09/14/2000 | CA2362427A1 Compositions and methods for the treatment of immune related diseases |
| 09/14/2000 | CA2362422A1 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | CA2362417A1 Class ii dna methyltransferases of zea mays |
| 09/14/2000 | CA2362414A1 Methods and reagents for identifying synthetic genetic elements |
| 09/14/2000 | CA2362370A1 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 09/14/2000 | CA2361927A1 End selection in directed evolution |
| 09/14/2000 | CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/14/2000 | CA2361370A1 Prevention and treatment of viral infections |
| 09/14/2000 | CA2331412A1 Method of identifying gene transcription patterns |
| 09/13/2000 | WO2001019181A1 Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine. |
| 09/13/2000 | EP1035220A2 Oligonucleotide primers for efficient multiplex detection of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) and methods of use thereof |
| 09/13/2000 | EP1035217A2 Method for prediction of PTH reactivity by polymorphism of PTHR gene |
| 09/13/2000 | EP1035215A2 Method and probe set for detecting cancer |
| 09/13/2000 | EP1035210A2 SIVagm-derived lentiviral vectors, processes for their preparation and their application in the gene transfer in mammalian cells |
| 09/13/2000 | EP1035209A1 Stable recombinant influenza viruses free of helper viruses |
| 09/13/2000 | EP1035208A1 VARIANT loxP SEQUENCES AND APPLICATION OF THE SAME |
| 09/13/2000 | EP1035207A1 cDNA molecules of the members of gene family encoding human fatty acid desaturases and their use in diagnosis and therapy |
| 09/13/2000 | EP1035206A1 Astaxanthin Synthetase |
| 09/13/2000 | EP1035205A1 Non-spreading pestivirus |
| 09/13/2000 | EP1035204A1 Steroid hormone binding protein |
| 09/13/2000 | EP1035203A1 Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants |
| 09/13/2000 | EP1035202A2 A cloning method for DNA fragments using arbitrarily primed PCR |
| 09/13/2000 | EP1035133A2 Fusion proteins comprising carriers that can induce a dual immune response |
| 09/13/2000 | EP1035129A1 A method of activating protein and an apparatus therefor |
| 09/13/2000 | EP1034785A2 Hepatitis C virus diagnostics and vaccines |
| 09/13/2000 | EP1034428A1 Method and device for disintegrating biological cells for the purpose of extracting and analyzing cell contents |
| 09/13/2000 | EP1034308A1 Method of generating conditionally expressed mutant cells using expressible antisense sequences |
| 09/13/2000 | EP1034307A1 Methods for the detection of chromosomal aberrations |
| 09/13/2000 | EP1034304A1 Method for measuring the apoptosis |
| 09/13/2000 | EP1034302A1 $i(DE NOVO) OR "UNIVERSAL" SEQUENCING ARRAY |
| 09/13/2000 | EP1034301A1 Inhibition of an fgf-binding protein using ribozymes |
| 09/13/2000 | EP1034300A1 Tetracycline assay method |
| 09/13/2000 | EP1034298A1 Humanization of murine antibody |
| 09/13/2000 | EP1034297A1 Murd protein and gene of staphylococcus aureus |
| 09/13/2000 | EP1034296A1 ribH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 09/13/2000 | EP1034295A1 ribA |
| 09/13/2000 | EP1034292A2 Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer |
| 09/13/2000 | EP1034291A2 Pseudo-type retroviral vectors with modifiable surface capsid proteins |
| 09/13/2000 | EP1034290A1 Flavivirus expression and delivery system |
| 09/13/2000 | EP1034289A1 Alphavirus vectors for paramyxovirus vaccines |
| 09/13/2000 | EP1034288A1 Methods of isolating and using cd7+cd34-lin-hematopoietic cells |
| 09/13/2000 | EP1034287A1 System and method for regulation of gene expression |
| 09/13/2000 | EP1034286A1 Mobilization of viral genomes from t-dna using site-specific recombination systems |
| 09/13/2000 | EP1034285A2 Isolation and characterization of plant regulatory sequences |
| 09/13/2000 | EP1034284A1 Method and compositions useful for the activation of silent transgenes |
| 09/13/2000 | EP1034283A2 Genetic engineering of lignin biosynthesis in plants |
| 09/13/2000 | EP1034282A1 Suicide expression vector for vaccine strains |
| 09/13/2000 | EP1034281A1 MAMMARY GLAND TISSUE-SPECIFIC EXPRESSION SYSTEM USING $G(b)-CASEIN PROMOTER SITE OF KOREAN NATIVE GOAT |
| 09/13/2000 | EP1034280A2 Cellulase produced by actinomycetes and method of producing same |
| 09/13/2000 | EP1034279A1 Human irak-2, a human interleukin-1 receptor associated kinase-2 |
| 09/13/2000 | EP1034278A1 Method for the production of glycerol by recombinant organisms |
| 09/13/2000 | EP1034277A2 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS) |
| 09/13/2000 | EP1034276A1 Novel era |
| 09/13/2000 | EP1034275A1 VACCINES FOR BLOCKING TRANSMISSION OF $i(PLASMODIUM VIVAX) |
| 09/13/2000 | EP1034274A2 Plant homologs of yeast pad1, yeast crm1, and human jab1: regulators of ap-1 type transcription factor activity |
| 09/13/2000 | EP1034273A1 Histamine and serotonin binding molecules |
| 09/13/2000 | EP1034272A1 A cDNA ENCODING C6 $g(b)-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN |
| 09/13/2000 | EP1034271A2 Transgenic non-human mammals with an oncogenic mutant of raf gene 1 |